Miproxifene
Miproxifene
Miproxifene (pronounced: mi-prox-i-fen) is a Selective Estrogen Receptor Modulator (SERM) that is primarily used in the treatment of breast cancer.
Etymology
The term "Miproxifene" is derived from the chemical name 2-(4-methyl-1-piperazinyl)-1-(4-(2-(2-pyridinyl)ethoxy)phenyl)-1-propanone. The name is a combination of the words "methyl", "piperazinyl", "phenyl", and "propanone", which are all components of the drug's chemical structure.
Usage
Miproxifene is used as a treatment for estrogen receptor-positive breast cancer. It works by blocking the effects of estrogen in the breast tissue, which can slow or stop the growth of certain types of breast cancer cells that need estrogen to grow.
Related Terms
- Selective Estrogen Receptor Modulator (SERM): A type of drug that acts on the estrogen receptor. Miproxifene is a type of SERM.
- Estrogen receptor: A protein found inside cells that binds to the hormone estrogen. Miproxifene works by blocking these receptors.
- Breast cancer: A type of cancer that forms in the cells of the breasts. Miproxifene is used to treat certain types of breast cancer.
Side Effects
Like all medications, Miproxifene can cause side effects. These may include hot flashes, nausea, vomiting, and weight gain. If these or any other side effects occur, it is important to contact a healthcare provider.
See Also
- Tamoxifen: Another type of SERM that is also used in the treatment of breast cancer.
- Raloxifene: A SERM used to prevent and treat osteoporosis in postmenopausal women.
External links
- Medical encyclopedia article on Miproxifene
- Wikipedia's article - Miproxifene
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski